...
首页> 外文期刊>Cornea >Long-term efficacy of phototherapeutic keratectomy on recurrent corneal erosion syndrome.
【24h】

Long-term efficacy of phototherapeutic keratectomy on recurrent corneal erosion syndrome.

机译:光疗性角膜切除术对复发性角膜侵蚀综合征的长期疗效。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To assess the long-term sequelae, principally time-to-first-recurrence, of phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome (RCES). METHODS: A retrospective case series was performed. Thirty-nine eyes in 33 patients with RCES required PTK and were treated using the VISX STAR Excimer Laser System. The data were analyzed with the Kaplan-Meier survival estimate. RESULTS: Patients were characterized by the cause of their RCES. More than 50% had epithelial corneal dystrophies, 31% were posttraumatic, and 15% were idiopathic. Overall, 25% of eyes had a recurrence by 3 months, and 36% had a recurrence by 9 months. The mean follow-up time was 17.4 months (range, 0.4-67.6 months). Of those who had a primary recurrence, 38% had a second and 15% had a third. Visual acuity was slightly decreased within 2 weeks after surgery, and 10% of patients developed transient haze. No serious adverse effects were reported. CONCLUSION: PTK is an important treatment of RCES refractory to other therapies. Long-term data suggest that most patients treated with PTK do not develop recurrences, and side effects from PTK are minimal.
机译:目的:评估光疗性角膜切除术(PTK)的长期后遗症,主要是首次复发时间,以治疗复发性角膜侵蚀综合征(RCES)。方法:回顾性病例系列。 33例RCES患者中有39眼需要PTK,并使用VISX STAR准分子激光系统进行了治疗。用Kaplan-Meier生存估计分析数据。结果:患者的特征在于其CESS的原因。超过50%的患者患有上皮角膜营养不良,创伤后为31%,特发性为15%。总体而言,有25%的眼睛在3个月后复发,有36%的眼睛在9个月后复发。平均随访时间为17.4个月(范围为0.4-67.6个月)。在原发性复发患者中,38%复发,15%复发。术后2周内视力略有下降,并且10%的患者出现短暂的雾霾。没有严重不良反应的报道。结论:PTK是其他疗法难治的RCES的重要治疗方法。长期数据表明,大多数接受PTK治疗的患者不会复发,并且PTK的副作用极小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号